These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 597414)

  • 21. Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.
    Nardelli B; Puccetti P; Romani L; Sava G; Bonmassar E; Fioretti MC
    Cancer Immunol Immunother; 1984; 17(3):213-7. PubMed ID: 6566603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased immunogenicity of two lymphoma lines after drug treatment of athymic (nude) mice.
    Campanile F; Houchens DP; Gaston M; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1975 Jul; 55(1):207-9. PubMed ID: 1159815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
    J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
    Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E
    J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of leukemic mice with viable drug-altered leukemic cells.
    Boerio D; Cavalli M; Marelli O; Veronese F; Nicolin A
    Ric Clin Lab; 1978; 8(3):127-33. PubMed ID: 746293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
    Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
    Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
    [No Abstract]   [Full Text] [Related]  

  • 30. [DTIC and its derivatives: cytotoxic or antimetastatic drugs?].
    Giraldi T; Sava G; Perissin L; Zorzet S; Tamaro M; Dolzani L
    G Ital Chemioter; 1985; 32(1):43-7. PubMed ID: 3830793
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
    Bonmassar A; Frati L; Fioretti MC; Romani L; Giampietri A; Goldin A
    Eur J Cancer (1965); 1979 Jul; 15(7):933-9. PubMed ID: 488153
    [No Abstract]   [Full Text] [Related]  

  • 32. Decrease in oncogenic potential of L1210 leukemia by triazenes.
    Schmid FA; Hutchison DJ
    Cancer Res; 1973 Sep; 33(9):2161-5. PubMed ID: 4725373
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanism of action of DTIC (NSC-45388).
    Bono VH
    Cancer Treat Rep; 1976 Feb; 60(2):141-8. PubMed ID: 944096
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors.
    Fisher JC; Cooperband SR; Mannick JA
    Cancer Res; 1972 May; 32(5):889-92. PubMed ID: 4336028
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stimulation of nonspecific body resistance in transplantation].
    Shcherbakova EG; Alekhin EK; Rastunova GA; Lazareva DN; Sobolev VR
    Antibiotiki; 1980 Sep; 25(9):675-9. PubMed ID: 6998369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
    Zola H
    Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic and virologic properties of chemically and gamma-irradiation-induced thymic lymphomas in mice.
    Chan PL; Sinclair NR
    J Natl Cancer Inst; 1972 Jun; 48(6):1629-40. PubMed ID: 5066471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.